For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes.

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

Over time, scar tissue slows or stops implanted bioelectronics. But new interdisciplinary research could help pacemakers, ...

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

In addition to the $1,500 grand prize, called the Lea Rudee Outstanding Poster Award, judges selected one student presenter ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group.

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...

The NSF has awarded a Faculty Early Career Development Program grant to Jing Li, assistant professor of medical chemistry and ...

Stealthy, subtle facelifts are on the rise, and it’s not just celebrities who are going under the knife. Katie Rosseinsky ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...